Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China · Delayed Price · Currency is CNY 14.64
+0.29 (2.02%)
Jul 1, 2026, 3:04 PM CST
SHE:002932 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,213 | 4,209 | 4,103 | 5,341 | 8,945 | 7,761 | |
Market Cap Growth | -25.74% | 2.60% | -23.18% | -40.29% | 15.26% | 78.41% |
Enterprise Value | 529 | 636 | 3,795 | 3,388 | 6,198 | 6,696 |
Last Close Price | 14.64 | 19.18 | 17.35 | 21.48 | 33.25 | 27.35 |
PE Ratio | - | - | 55.06 | 71.28 | 2.13 | 5.49 |
PS Ratio | 12.09 | 15.88 | 11.72 | 7.13 | 0.85 | 2.74 |
PB Ratio | 0.57 | 0.74 | 0.68 | 0.85 | 1.32 | 2.72 |
P/TBV Ratio | 0.59 | 0.77 | 0.71 | 0.89 | 1.38 | 2.80 |
P/FCF Ratio | - | - | - | 18.91 | 2.42 | 7.58 |
P/OCF Ratio | - | - | - | 13.61 | 2.23 | 6.89 |
EV/Sales Ratio | 1.99 | 2.40 | 10.84 | 4.52 | 0.59 | 2.37 |
EV/EBITDA Ratio | - | - | - | 57.13 | 1.20 | 3.93 |
EV/EBIT Ratio | - | - | - | - | 1.21 | 3.98 |
EV/FCF Ratio | - | - | - | 11.99 | 1.68 | 6.54 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.02 |
Debt / EBITDA Ratio | - | - | - | 0.64 | 0.04 | 0.03 |
Debt / FCF Ratio | - | - | - | 0.17 | 0.06 | 0.04 |
Net Debt / Equity Ratio | -0.50 | -0.69 | -0.23 | -0.19 | -0.65 | -0.65 |
Net Debt / EBITDA Ratio | 20.71 | 25.27 | 15.64 | -20.09 | -0.84 | -1.08 |
Net Debt / FCF Ratio | 21.93 | 24.09 | 5.17 | -4.22 | -1.18 | -1.80 |
Asset Turnover | 0.04 | 0.04 | 0.05 | 0.09 | 1.67 | 1.17 |
Inventory Turnover | 1.81 | 2.43 | 2.06 | 1.60 | 14.70 | 3.52 |
Quick Ratio | 13.11 | 18.54 | 4.55 | 2.52 | 3.10 | 4.84 |
Current Ratio | 18.35 | 19.43 | 4.84 | 2.70 | 3.25 | 5.50 |
Return on Equity (ROE) | -1.20% | -1.29% | 0.43% | 1.06% | 91.05% | 72.97% |
Return on Assets (ROA) | -1.87% | -2.04% | -1.31% | -0.05% | 50.90% | 43.43% |
Return on Invested Capital (ROIC) | -8.09% | -6.41% | -2.47% | -0.09% | 260.54% | 206.48% |
Return on Capital Employed (ROCE) | -3.20% | -3.60% | -2.40% | -0.10% | 75.20% | 58.60% |
Earnings Yield | -0.41% | -0.39% | 1.82% | 1.40% | 47.05% | 18.21% |
FCF Yield | -4.01% | -3.82% | -6.58% | 5.29% | 41.36% | 13.19% |
Dividend Yield | - | - | 7.09% | 0.56% | 10.50% | 7.41% |
Payout Ratio | - | - | 45.87% | 777.41% | 13.08% | 20.05% |
Buyback Yield / Dilution | -2.37% | -4.13% | 0.54% | 1.22% | -8.61% | -1.43% |
Total Shareholder Return | -2.37% | -4.13% | 7.63% | 1.78% | 1.89% | 5.98% |